LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
Not yet recruiting · NCT04657965 · Registry updated 2020-12-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies | Disease Attributes, Hemic and Lymphatic Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, hematopoietic and lymphoid system neoplasm, infectious disease, neoplasm | Not yet recruiting | Early phase 1 | 2020-12-08 | NCT04657965 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yake Biotechnology Ltd. | 30 |
| Zhejiang University | 194 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital，College of Medicine, Zhejiang University | Hangzhou | China | 8 |